Characterizing the Burden of Hand Dermatitis in Canada: A Cross-Sectional Survey of Disease Impact (EADV 2026) - Aug 6, 2026 - Abstract #P1592; AS-1487; Pres time: Sep 30, 2026; Location: ePoster Area; "Current use of systemic agents, such as biologics (8.3%), oral JAK inhibitors (3.0%), or alitretinoin (1.3%) was low despite the degree of patient reported severity...Additionally, these findings highlight the need for potential updates to the Canadian hand dermatitis management guidelines which have not been updated since 2010. Study limitations include selection bias and reliance on self-reported outcomes inherent to a survey study."
Contact Dermatitis • Dermatitis • Dermatology • Dermatopathology • Immunology • Mood Disorders • Pruritus
|
|
Amanda Cresswell-Melville; Shanti Mehta; Dea Metko; Robert Bissonnette; Sonja Molin
|